Format

Send to

Choose Destination
See comment in PubMed Commons below
J Clin Oncol. 1992 Jun;10(6):1014-24.

Inflammatory breast cancer: a review.

Author information

  • 1Department of Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston 77030.

Abstract

PURPOSE:

The natural history of inflammatory breast cancer and the recent advances in its management were reviewed.

DESIGN:

The English medical literature from 1924 to 1990 was reviewed using the Cancerline and Medline retrieval systems, and through a manual review of bibliographies of identified articles.

RESULTS:

The majority of patients with inflammatory breast cancer treated only with local therapies died 18 to 24 months after diagnosis. A combined modality approach with chemotherapy, surgery, and radiation therapy has improved disease-free and overall survival rates for inflammatory breast cancer. Approximately 35% to 55% of patients treated with combined modality regimens remain disease-free and alive at 5 years.

CONCLUSION:

Induction combination chemotherapy administered with radiation therapy, mastectomy, both, or with additional chemotherapy favorably alters the natural history of inflammatory breast cancer. New drug combinations and high-dose chemotherapy with autologous bone marrow support are being evaluated to improve further patient survival.

PMID:
1588366
DOI:
10.1200/JCO.1992.10.6.1014
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Atypon
    Loading ...
    Support Center